Literature DB >> 3567650

Dopamine-like action of nicotine: lack of tolerance and reverse tolerance.

E P Lapin, H S Maker, H Sershen, Y Hurd, A Lajtha.   

Abstract

Rats with unilateral 6-hydroxydopamine lesions of the substantia nigra became briefly sedated and hypothermic after the acute injection of nicotine s.c. (0.4 or 0.8 mg/kg free base). When nicotine was repeated 5 days per week there was rapid tolerance for the sedation and slower tolerance for the hypothermia and the lesioned animals began to rotate ipsiversively after each injection. Stereotypic behavior was also noted. Rats injected with nicotine 5 days per week and nigrally lesioned on the 24th day rotated promptly on their first postoperative injection of nicotine. The nicotinic antagonist, mecamylamine (1.0 mg/kg i.p.), completely blocked the induced rotation. The appearance of rotation did not seem to depend on tolerance to sedation. The direction of rotation indicated enhancement of activity in the intact nigrostriatal system. However, 10 min after the acute injection of 0.8 mg/kg nicotine no change was found in the ratios of dopamine to its metabolites DOPAC and homovanillic acid in the substantia nigra, caudate-putamen, nucleus accumbens, olfactory tubercle, frontal cortex, or ventral tegmental area. Rats given 0.4 or 0.8 mg/kg nicotine 5 days per week and either lesioned prior to nicotine or lesioned during the third week rotated during the sixth week without any sign of tolerance. One day after the 30th injection in intact or lesioned rats the ratios of dopamine to its metabolites did not differ from those in saline controls on either the right or left side of any of the regions examined. There was no evidence of a change in dopamine metabolism after an acute challenge with nicotine or of a sustained change after repeated injection. The possibility remains that repeated nicotine modifies the dopaminergic response to nicotine without causing a sustained change in metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567650     DOI: 10.1016/0006-8993(87)91114-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis.

Authors:  M S Reid; L B Ho; S P Berger
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

2.  Acute reduction of brain substance P induced by nicotine.

Authors:  N E Naftchi; H Maker; E Lapin; J Sleis; A Lajtha; S Leeman
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

3.  Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.

Authors:  Luping Z Huang; Sharon R Grady; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2011-06-10       Impact factor: 4.030

4.  The short-term effect of nicotine chewing gum in patients with Parkinson's disease.

Authors:  P Clemens; J A Baron; D Coffey; A Reeves
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

5.  Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum.

Authors:  T Leikola-Pelho; J Heinämäki; I Laakso; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

6.  Conditioning of nicotine effects on motility and behaviour in rats.

Authors:  S Walter; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

7.  Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Authors:  Elizabeth Watterson; Alexander Spitzer; Lucas R Watterson; Ryan J Brackney; Arturo R Zavala; M Foster Olive; Federico Sanabria
Journal:  Behav Brain Res       Date:  2016-06-27       Impact factor: 3.332

8.  Locomotor activity in rats after administration of nicotinic agonists intracerebrally.

Authors:  C Reavill; I P Stolerman
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.

Authors:  M E Benwell; D J Balfour
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

10.  An analysis of response to nicotine infusion using an automated radiotelemetry system.

Authors:  S F Robinson; J R Pauly; M J Marks; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.